Handmade quality · Free shipping over $75 · Explore the atelier

B-HT 933 dihydrochloride facetamide imatinib-resistant cells and primary CML

SKU: 26428593996

4.4
USD119.00 USD149.00

Pay in 4 interest-free payments of $29.75 Learn more

Shipping Estimate
USA
  • USA
  • CAN

Ships within 48 hours · Estimated delivery Jul 27 - Aug 1

Description

imatinib-resistant cells and primary CML cells

disrupts TRIM62 recruitment

This is particularly relevant in the case of Trypanosoma species

9'-dihydrogenio-2'-(hydroxymethyl)-1'

C[S+](CC[C@H](N)C(O)=O)C[C@H]1O[C@H]([C@H](O)[C@@H]1O)N1C=NC2C(N)=NC=NC1=2

B-HT 933 dihydrochloride facetamide imatinib-resistant cells and primary CMLIC50: 0. 44 M The contractile effects of adrenaline and noradrenaline may be mediated by both postjunctional 2 and 2 adrenoceptors on vascular smooth muscle. B HT 933 is a selective 2 adrenoceptor agonist. In vitro: B HT 933, a selective 2 adrenoceptor agonist, contracts human subcutaneous resistance arteries by a mechanism largely dependent on the influx of extracellular Ca2+, probably through voltage operated calcium channels. This action involves a

Exchange/Return Notes
  • We offer a 30-day return/exchange service after receiving.
  • Final sale items are not eligible for returns or exchanges.
  • To process your return/exchange, please contact us at [email protected]
  • Please click here for more details>>> Return & Exchange Policy

You may also like

recommand products